BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schneider G, Wirth M, Keller U, Saur D. Rationale for MYC imaging and targeting in pancreatic cancer. EJNMMI Res 2021;11:104. [PMID: 34637026 DOI: 10.1186/s13550-021-00843-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Elakad O, Yao S, von Hammerstein-Equord A, Hinterthaner M, Danner BC, Ferrai C, Ströbel P, Küffer S, Bohnenberger H. Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma. Metabolites 2022;12:652. [PMID: 35888776 DOI: 10.3390/metabo12070652] [Reference Citation Analysis]
2 Wirth M. Targeting the translational machinery to overcome apoptosis resistance in pancreatic cancer. Transl Oncol 2022;17:101343. [PMID: 35078019 DOI: 10.1016/j.tranon.2022.101343] [Cited by in F6Publishing: 1] [Reference Citation Analysis]